Ligand validation:5PH9

OGA: N-OXALYLGLYCINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5PH9_OGA_A_403	77%	17%	0.101	0.941	2.33	1.33	1	3	0	0	100%	0.78
5PH2_OGA_A_403	97%	14%	0.059	0.976	2.35	1.5	1	3	0	0	100%	0.97
5PHN_OGA_A_403	91%	18%	0.077	0.964	2.18	1.35	1	2	1	0	100%	0.84
5PH6_OGA_A_403	90%	18%	0.077	0.959	2.29	1.24	1	1	0	0	100%	1
5PH7_OGA_A_403	90%	18%	0.074	0.955	2.29	1.24	1	2	0	0	100%	0.91
5PHA_OGA_A_403	89%	17%	0.078	0.957	2.34	1.32	1	1	1	0	100%	0.89
4GJY_OGA_A_502	100%	25%	0.024	0.993	2.38	0.72	2	-	0	0	100%	1
3MS5_OGA_A_390	99%	26%	0.048	0.984	1.22	1.76	1	3	0	0	100%	1
5A1F_OGA_A_1756	99%	17%	0.054	0.985	2.18	1.44	2	2	0	0	100%	1
6F4T_OGA_A_502	98%	14%	0.053	0.979	2.26	1.62	4	2	0	0	100%	1
6F4R_OGA_A_502	98%	20%	0.062	0.984	1.98	1.4	1	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.